4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001193125-26-140164
Options or other derivatives
- Chief Executive Officer acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mohindru Mani Chief Executive Officer | 2026-03-31 | Grant or award · Stock Options | +600,000 | 968,766 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…